review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Wilson A | |
Donaldson MD | |||
Stephenson JB | |||
Cooke A | |||
Greene SA | |||
Chu CE | |||
P2860 | cites work | Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region | Q28208127 |
Genomic imprinting: review and relevance to human diseases. | Q30501672 | ||
Molecular dissection of the Prader-Willi/Angelman syndrome region (15q11-13) by YAC cloning and FISH analysis | Q31165084 | ||
Precocious puberty in a male with Prader-Labhart-Willi syndrome | Q70519795 | ||
The Prader-Willi syndrome | Q71278557 | ||
Prader-Willi syndrome: neonatal presentation and later development | Q71436966 | ||
Endocrine function in the Prader-Willi syndrome | Q71503870 | ||
The Prader-Willi syndrome with a 15/15 translocation. Case report and review of the literature | Q33586909 | ||
An anthropometric study of 38 individuals with Prader-Labhart-Willi syndrome | Q33828442 | ||
Prader-Willi syndrome: current understanding of cause and diagnosis | Q33858951 | ||
Prader-Willi syndrome: consensus diagnostic criteria. | Q34061685 | ||
FISH ordering of reference markers and of the gene for the alpha 5 subunit of the gamma-aminobutyric acid receptor (GABRA5) within the Angelman and Prader-Willi syndrome chromosomal regions | Q34356063 | ||
Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion | Q34461093 | ||
Physical features of Prader-Willi syndrome in neonates | Q34636505 | ||
Deletions of chromosome 15 as a cause of the Prader-Willi syndrome | Q34718526 | ||
Prader-Willi Syndrome after age 15 years | Q35114940 | ||
Occupational hydrocarbon exposure among fathers of Prader-Willi syndrome patients with and without deletions of 15q. | Q35248500 | ||
Isolation of molecular probes associated with the chromosome 15 instability in the Prader-Willi syndrome | Q35611528 | ||
Fenfluramine in Prader-Willi syndrome: a double blind, placebo controlled trial | Q35625284 | ||
Multiplex PCR of three dinucleotide repeats in the Prader-Willi/Angelman critical region (15q11-q13): molecular diagnosis and mechanism of uniparental disomy. | Q36783665 | ||
The Prader-Labhart-Willi syndrome: review of the literature and report of nine cases | Q40065565 | ||
DNA deletion and its parental origin in Angelman syndrome patients | Q41135500 | ||
Beta-endorphin immunoreactivity in the plasma of patients with the Prader-Labhart-Willi syndrome and their normal siblings | Q41556526 | ||
Prader-Willi syndrome in siblings, due to unbalanced translocation between chromosomes 15 and 22. | Q41790276 | ||
Weight control of children with Prader-Willi syndrome | Q44413279 | ||
Linear growth response to exogenous growth hormone in Prader-Willi syndrome. | Q45084955 | ||
Immunoreactive insulin and growth hormone responses in patients with Prader-Willi syndrome | Q47974200 | ||
Anterior Pituitary Function in the Prader-Labhart-Willi (PLW) Syndrome | Q48499530 | ||
The speech and language characteristics of children with Prader-Willi syndrome. | Q50551149 | ||
The effects of naltrexone, an oral beta-endorphin antagonist, in children with the Prader-Willi syndrome. | Q51206919 | ||
Plasma immunoreactive beta-melanocyte stimulating hormone (lipotropin) levels in individuals with Prader-Labhart-Willi syndrome. | Q51627675 | ||
A reduced number of insulin receptors in patients with Prader-Willi syndrome | Q51645463 | ||
Metabolic aspects of a protein-sparing modified fast in the dietary management of Prader-Willi obesity | Q51667628 | ||
Emotional symptoms in Prader-Willi syndrome adolescents. | Q52583296 | ||
Adults with Prader-Willi syndrome: abnormalities of sleep and behaviour. | Q55311630 | ||
Gastric bypass for morbid obesity in children and adolescents | Q66913734 | ||
Maternal but not paternal transmission of 15q11-13-linked nondeletion Angelman syndrome leads to phenotypic expression | Q67510275 | ||
Neonatal Presentation of Prader-Willi Syndrome | Q67735614 | ||
Out-patient dietary management in the Prader-Willi syndrome | Q67757944 | ||
Food and children with Prader-Willi syndrome | Q67829369 | ||
Standards for selected anthropometric measurements in Prader-Willi syndrome | Q67979069 | ||
Molecular diagnosis of the Prader-Willi and Angelman syndromes by detection of parent-of-origin specific DNA methylation in 15q11-13 | Q67993243 | ||
A nutrition survey of and recommendations for individuals with Prader-Willi syndrome who live in group homes | Q68195829 | ||
Energy expenditure and body composition in Prader-Willi syndrome | Q68260755 | ||
Molecular study of the Prader-Willi syndrome: Deletion, RFLP, and phenotype analyses of 50 patients | Q68324405 | ||
Growth hormone secretion in Prader-Willi syndrome | Q68644237 | ||
Adults with Prader-Willi syndrome: a survey of 232 cases | Q69022332 | ||
Familial Prader-Willi syndrome with apparently normal chromosomes | Q69437089 | ||
Recurrence risk in Prader-Willi syndrome | Q69437094 | ||
Paternal hydrocarbon exposure in Prader-Willi syndrome | Q69911063 | ||
Evidence against growth hormone-releasing factor deficiency in children with idiopathic obesity | Q70310886 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 58-63 | |
P577 | publication date | 1994-01-01 | |
P1433 | published in | Archives of Disease in Childhood | Q4787296 |
P1476 | title | The Prader-Willi syndrome | |
P478 | volume | 70 |
Q80520026 | Anthropometric and intellectual evaluation of individuals with Prader-Willi syndrome |
Q57905283 | Bilateral non-communicating paraurethral meatus in Prader-Willi syndrome |
Q33721923 | Childhood leukaemia: a model of pre-obesity. |
Q33683182 | Clinical features in 27 patients with Angelman syndrome resulting from DNA deletion. |
Q35800882 | Clinical implications of gait analysis in the rehabilitation of adult patients with "Prader-Willi" Syndrome: a cross-sectional comparative study ("Prader-Willi" Syndrome vs matched obese patients and healthy subjects) |
Q34796000 | Comparison of high resolution cytogenetics, fluorescence in situ hybridisation, and DNA studies to validate the diagnosis of Prader-Willi and Angelman's syndromes |
Q72318701 | Diagnosing Prader-Willi syndrome |
Q33625228 | Diagnosis in Prader-Willi syndrome |
Q41778628 | Disorders of Sleep and Ventilatory Control in Prader-Willi Syndrome |
Q52383122 | Down's 1864 case of Prader-Willi syndrome: a follow-up report. |
Q48400084 | Efficacy and safety of adenotonsillectomy for pediatric obstructive sleep apnea in Prader-Willi syndrome |
Q34500128 | Experimental analyses of gene-brain-behavior relations: some notes on their application |
Q57162083 | Familial translocation t(Y;15)(q12;p11) and de novo deletion of the Prader-Willi syndrome (PWS) critical region on 15q11-q13 |
Q48868755 | GH secretion in Prader-Labhard-Willi syndrome: somatotrope responsiveness to GHRH is enhanced by arginine but not by pyridostigmine |
Q38312497 | GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology |
Q35090199 | Growth hormone therapy in the Prader-Willi syndrome. |
Q35702116 | Growth hormone treatment in children: review of safety and efficacy |
Q48694946 | Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors |
Q34532776 | Hypogonadism and pubertal development in Prader-Willi syndrome. |
Q38299914 | Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome |
Q51988153 | Language development in a 3-year-old boy with Prader-Willi syndrome. |
Q64045427 | Multicentre study of maternal and neonatal outcomes in individuals with Prader-Willi syndrome |
Q52649236 | Neonatal Features of The Prader-Willi Syndrome; The Case for Making The Diagnosis During The First Week of Life. |
Q51949207 | Obstetric aspects of the Prader–Willi syndrome |
Q35173600 | Periodontal disease in a patient with Prader-Willi syndrome: a case report. |
Q96304615 | Polyhydramnios and abnormal foetal heart rate patterns in a foetus with Prader-Willi syndrome: A case report |
Q33832512 | Prader-Willi syndrome, diabetes mellitus and hypogonadism |
Q51982206 | Prader-Willi syndrome. |
Q37784976 | Prader–Willi syndrome: sorting out the relationships between obesity, hypersomnia, and sleep apnea |
Q35249345 | Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes |
Q38683706 | Sleep Disturbances in Neurodevelopmental Disorders. |
Q34804102 | Sleep and breathing in Prader-Willi syndrome |
Q45399577 | The proportion of uniparental disomy is increased in Prader-Willi syndrome due to an advanced maternal childbearing age in Korea |
Q51987714 | Troglitazone ameliorates insulin resistance in a diabetic patient with Prader-Willi syndrome. |
Q41167741 | Why is there no diploid overdose effect in Prader-Willi syndrome due to uniparental disomy? |
Q77366010 | [Unusual mechanism in Prader-Willi syndrome: incidence in genetic counseling] |
Search more.